This inventor holds 2 USPTO granted patents and 3 published patent applications and 6 EPO patents. Top assignees: Helmholtz-Zentrum Für, Helmholtz-Zentrum Fur Infektionsforschung Gmbh, Infektionsforschung Gmbh. Active years: 2021-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 28 
1 out of 1 
Years Active: 2021-2022
Title: Mark Brönstrup: Innovator in Anti-Viral and Bacterial Treatments
Introduction
Mark Brönstrup is a notable inventor based in Braunschweig, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds for treating infectious diseases. With a total of 2 patents, his work focuses on innovative solutions to combat viral and bacterial infections.
Latest Patents
Brönstrup's latest patents include groundbreaking research on labyrinthopeptins as anti-viral agents. This invention relates to novel labyrinthopeptin derivatives that are effective in treating various infectious diseases caused by viruses such as human respiratory syncytial virus (RSV), Kaposi sarcoma-associated herpesvirus (KSHV), cytomegalovirus (CMV), dengue virus (DENV), chikungunya virus (CHIKV), tick-borne encephalitis virus (TBEV), vesicular stomatitis Indiana virus (VSV), zika virus (ZIKV), and hepatitis C virus (HCV). Additionally, his work encompasses a combination of labyrinthopeptin A1 and A2 for use as a medicament against these infections. Another significant patent involves cystobactamide derivatives, which are novel compounds aimed at the treatment or prophylaxis of bacterial infections.
Career Highlights
Throughout his career, Mark Brönstrup has worked with esteemed institutions such as Helmholtz-Zentrum für Infektionsforschung GmbH and Medizinische Hochschule Hannover. His research has been pivotal in advancing the understanding and treatment of infectious diseases.
Collaborations
Brönstrup has collaborated with notable colleagues, including Hans-Peter Prochnow and Nv Suryanarayana Birudukota. These partnerships have contributed to the success of his innovative research.
Conclusion
Mark Brönstrup's contributions to the field of medicinal chemistry highlight his commitment to developing effective treatments for infectious diseases. His innovative patents and collaborations underscore the importance of research in combating health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile